JAZZ vs MOD · P/E 1988, rev $4.07B vs P/E 126, rev $2.58B
Jazz Pharmaceuticals PLC (JAZZ) versus Modine Manufacturing Company (MOD) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Modine Manufacturing Company (MOD) is a auto parts company listed on US.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported MOD revenue for 2025-03-31 was $2.58B. Net income was $185.5M. Revenue was up 7.3% from 2024-03-31 to 2025-03-31. MOD currently screens at market cap $14.99B and trailing P/E 126.2.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. MOD currently screens at market cap $14.99B and trailing P/E 126.2.
Not investment advice. Open the JAZZ and MOD stock pages for the full models.
Not investment advice.